Ignite Creation Date:
2024-05-06 @ 8:34 AM
Last Modification Date:
2024-10-26 @ 12:02 PM
Study NCT ID:
NCT02767661
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-16
First Post:
2016-05-07
Brief Title:
Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR Her2- Metastatic Breast Cancer
Sponsor:
Sun Yat-sen University
Organization:
Sun Yat-sen University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-19
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-05
Completion Date Type:
ESTIMATED
First Submit Date:
2016-05-07
First Submit QC Date:
May 7 2016
Study First Post Date:
2016-05-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-15
Last Update Post Date:
2024-02-16
Last Update Post Date Type:
ACTUAL